1.
Am J Transplant
; 17(1): 292-295, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27501470
RESUMO
The concern about cancer recurrence has traditionally resulted in delaying kidney transplantation for 2-5 years after a cancer diagnosis in patients who are otherwise eligible for transplant. This period of inactive status to observe the tumor biology can result in significant morbidity and decreased quality of life for patients with end-stage renal disease (ESRD). We reported the novel application of genomic profiling assays in breast cancer to identify low-risk cancers in two patients with ESRD who were able to have the mandatory inactive status eliminated prior to kidney transplantation.
Assuntos
Biomarcadores Tumorais/genética , Neoplasias da Mama/patologia , Perfilação da Expressão Gênica , Transplante de Rim , Recidiva Local de Neoplasia/diagnóstico , Neoplasias da Mama/genética , Feminino , Genômica , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/genética , Prognóstico , Fatores de Risco , Transplantados
2.
Clin Chem
; 36(8 Pt 1): 1519, 1990 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-2201461